Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Genzyme General discontinues U.S. development of Sepracoat

Jan. 15, 1998

New class of glucocorticoids with an improved pharmacological profile

Jan. 15, 1998

IMPDH inhibitor VX-497 advances to clinical trials

Jan. 14, 1998

OrthoLogic makes equity investment in Chrysalis; acquires rights to new peptide

Jan. 13, 1998

Cellegy acquires Anogesic

Jan. 13, 1998

ADCON-L submitted to regulatory authorities

Jan. 9, 1998

ABX-IL-8 slated to enter clinical testing

Jan. 8, 1998

NDA filed for betamethasone mousse

Jan. 7, 1998

Biomatrix's Hyalform approved in additional markets; PMA resubmission planned in U.S.

Jan. 5, 1998

Structurally distinct vitamin D analogues from Leo

Jan. 5, 1998

Popular Stories

Today's news in brief
BioWorld
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...